ADIL
Companies
NASDAQ
Adial Pharmaceuticals Inc.
Health Care
$0.24
-$0.77 (-76.56%)
Price Chart
Overview
About ADIL
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.
Market Cap
$5.2M
Volume
47.4K
Avg. Volume
272.4K
P/E Ratio
-0.54624057
Dividend Yield
0.00%
Employees
6.0
Company Information
Risk & Correlation Analysis
Market Correlation
0.92
Moderate Correlation
Volatility
High (1.00)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Medium Sensitivity
GDP Growth
High Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, ADIL shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$5.2M
Volume47.4K
P/E Ratio-0.55
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 15, 2025Related Securities
Pricing info last updated June 17, 2025 (after market close)Other info last updated April 2, 2025